Obstetrics, gynecology and reproductive medicine guidelines

Obesity, eating disorders

PubMed Free Full Text

Obesity: pharmacologic treatment

 

Australia

• Australian Family Physician
  • Pharmacotherapy for obesity [2017]

Cochrane

• Cochrane Library
  • Rimonabant for overweight or obesity
  • Long-term pharmacotherapy for obesity and overweight
  • Long-term effects of weight-reducing drugs in hypertensive patients
  • Green tea for weight loss and weight maintenance in overweight or obese adults
  • Drug interventions for the treatment of obesity in children and adolescents
  • Chitosan for overweight or obesity

Europe

• European Association for the Study of Obesity
  • 2014 EASO Position Statement on the Use of Anti-Obesity Drugs [2015]

International

• BMC Medicine
  • Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review [2016]

Saudi Arabia

• Scientific World Journal
  • Safety Evaluation of Local Weight-Gain Formulas in the Saudi Arabian Markets [2015]

United Kingdom

• National Institute for Health and Care Excellence
  • Obese, overweight with risk factors: liraglutide (Saxenda) [2017]
  • Naltrexone–bupropion for managing overweight and obesity [2017]

United States of America

• Endocrine Society
  • Pharmacological management of obesity: an Endocrine Society clinical practice guideline [2015]

• National Guideline Clearinghouse
  • Pharmacological management of obesity: an Endocrine Society clinical practice guideline [2014]

• Obesity
  • Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010 [2015]

{Related topics}

• Guidelines
  • Obesity, weight loss